SCHV vs XLV
Schwab US Large-Cap Value ETF vs Health Care Select Sector SPDR Fund
- • SCHV has the lower expense ratio at 0.04% vs 0.08% for XLV.
- • SCHV pays a higher dividend yield (1.75%).
Side-by-side metrics
| Metric | SCHV | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.04% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.75% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $15.93B | $40.60B |
YTD return | 16.15% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.76 | 0.51 |
P/E ratio | 22.31 | 29.18 |
Last price | $34.32 | $162.17 |
Inception | — | — |
Issuer | Schwab | State Street |
SCHV top holdings
| MU | Micron Technology Inc | 4.02% |
| BRK-B | Berkshire Hathaway Inc Class B | 2.83% |
| JPM | JPMorgan Chase & Co | 2.75% |
| INTC | Intel Corp | 1.94% |
| JNJ | Johnson & Johnson | 1.94% |
| XOM | Exxon Mobil Corp | 1.76% |
| AMAT | Applied Materials Inc | 1.72% |
| LRCX | Lam Research Corp | 1.60% |
| WMT | Walmart Inc | 1.57% |
| CAT | Caterpillar Inc | 1.48% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
About SCHV
SCHV (Schwab US Large-Cap Value ETF) is Large-cap US value at low cost. Managed by Schwab, the fund carries $15.9B in assets under management, an expense ratio of 0.04%, a dividend yield of 1.75%. Its largest holding is Micron Technology Inc (MU), which represents 4.0% of the portfolio. Real Estate is the fund's largest sector exposure at 3.9%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.